Market Overview:
The global percutaneous transhepatic cholangiography (PTC) market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of biliary diseases, technological advancements in PTC devices, and rising demand for minimally invasive procedures. However, the high cost of PTC procedures may restrain the market growth during the forecast period. Based on type, the global PTC market is segmented into PTC plastic pancreatic & biliary stenting procedures and PTC metal pancreatic & biliary stenting procedures. The plastic pancreatic & biliary stenting procedure segment dominated the global market in 2017 and is projected to maintain its dominance during the forecast period owing to its low cost and easy availability as compared to metal pancreatic & biliary stenting procedure. Based on application, the global PTC market is segmented into jaundice, stone removal, postoperative or posttraumatic bile leakage, others (including diagnosis of cancer). Jaundice was estimated as one of leading indications for performing a percutaneous transhepatic cholangiography in 2017 owing to high prevalence rate across all regions studied in this research study.
Product Definition:
Percutaneous transhepatic cholangiography is an imaging test used to look at the bile ducts inside the liver. It is done by putting a thin, flexible tube (catheter) through a small cut (incision) in your skin and into the liver. A contrast material is then injected into the bile ducts. This material helps show any problems or blockages in the ducts on an x-ray image.
PTC Plastic Pancreatic & Biliary Stenting Procedures:
PTC is a minimally invasive procedure used to treat slow-moving or blocked bile ducts in patients suffering from liver cirrhosis, cancer, and other chronic diseases. The PTC device comprises of a flexible tube called as stent that is inserted through the patient’s skin into the blood vessels near the liver. This stent then allows doctors and medical staff to view and operate on damaged areas of the liver during endoscopic procedures.
PTC Metal Pancreatic & Biliary Stenting Procedures:
PTC metal pancreatic and biliary stenting procedures are used in Percutaneous Transhepatic Cholangiography (PCTC) to treat slow moving or blockage of the bile duct. The stent is placed inside the liver and it allows the doctors to view & operate inside the body.
Application Insights:
The jaundice segment dominated the global percutaneous transhepatic cholangiography market in 2017. The growth of this segment can be attributed to the rising prevalence of jaundice due to biliary atresia and other causes. Percutaneous transhepatic cholangiography is used for diagnosis as well as treatment of various conditions, such as biliary atresia, primary sclerosing cholangitis (PSC), and others. PTC procedures are considered a gold standard for liver disease management; however, they are not always an option due to contraindications or intolerance with regard to patient age group or condition severity. In such cases, endoscopic liver surgery (ELS) is preferred over PTC procedures owing to its lesser invasiveness and shorter recovery time post-surgery than that after PTC procedure.
Regional Analysis:
North America dominated the global percutaneous transhepatic cholangiography market in 2017. This can be attributed to the presence of well-established healthcare facilities, high adoption rate of advanced technologies, and availability of skilled physicians & surgeons. Moreover, increasing prevalence of liver diseases is also expected to drive regional growth over the forecast period. In addition, rising awareness about various treatment options through various programs conducted by medical associations and government organizations is further anticipated to fuel demand for PTC procedures in this region.
Growth Factors:
- Increasing incidence of biliary tract diseases: The increasing incidence of biliary tract diseases is one of the key growth drivers for the percutaneous transhepatic cholangiography (PTC) market. This is because PTC is a minimally invasive diagnostic procedure that helps in the diagnosis and treatment of various biliary tract diseases.
- Rising demand for early diagnosis and treatment: The rising demand for early diagnosis and treatment is another key growth driver for the PTC market. This is because PTC helps in the early detection and treatment of various biliary tract diseases, which can help improve patient outcomes.
- Technological advancements: The technological advancements in PTC devices are another key growth driver for this market. These advancements have helped to make these devices more user-friendly, thus resulting in an increase in their adoption rates worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Percutaneous Transhepatic Cholangiography Market Research Report
By Type
PTC Plastic Pancreatic & Biliary Stenting Procedures, PTC Metal Pancreatic & Biliary Stenting Procedures
By Application
Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Others
By Companies
B. Braun Melsungen AG, KARL STORZ, Cardinal Health, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Percutaneous Transhepatic Cholangiography Market Report Segments:
The global Percutaneous Transhepatic Cholangiography market is segmented on the basis of:
Types
PTC Plastic Pancreatic & Biliary Stenting Procedures, PTC Metal Pancreatic & Biliary Stenting Procedures
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun Melsungen AG
- KARL STORZ
- Cardinal Health
- GE Healthcare
Highlights of The Percutaneous Transhepatic Cholangiography Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PTC Plastic Pancreatic & Biliary Stenting Procedures
- PTC Metal Pancreatic & Biliary Stenting Procedures
- By Application:
- Jaundice
- Stone Removal
- Postoperative or Posttraumatic Bile Leakage
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Percutaneous Transhepatic Cholangiography Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Percutaneous transhepatic cholangiography (PTC) is a minimally invasive procedure that uses a catheter to inject dye into the bile ducts and view the liver on an x-ray. PTC can help diagnose and treat various diseases of the liver, including cirrhosis.
Some of the major players in the percutaneous transhepatic cholangiography market are B. Braun Melsungen AG, KARL STORZ, Cardinal Health, GE Healthcare.
The percutaneous transhepatic cholangiography market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Percutaneous Transhepatic Cholangiography Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Percutaneous Transhepatic Cholangiography Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Percutaneous Transhepatic Cholangiography Market - Supply Chain
4.5. Global Percutaneous Transhepatic Cholangiography Market Forecast
4.5.1. Percutaneous Transhepatic Cholangiography Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Percutaneous Transhepatic Cholangiography Market Size (000 Units) and Y-o-Y Growth
4.5.3. Percutaneous Transhepatic Cholangiography Market Absolute $ Opportunity
5. Global Percutaneous Transhepatic Cholangiography Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Type
5.3.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
5.3.2. PTC Metal Pancreatic & Biliary Stenting Procedures
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Percutaneous Transhepatic Cholangiography Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
6.3.1. Jaundice
6.3.2. Stone Removal
6.3.3. Postoperative or Posttraumatic Bile Leakage
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Percutaneous Transhepatic Cholangiography Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Percutaneous Transhepatic Cholangiography Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Percutaneous Transhepatic Cholangiography Demand Share Forecast, 2019-2026
9. North America Percutaneous Transhepatic Cholangiography Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
9.4.1. Jaundice
9.4.2. Stone Removal
9.4.3. Postoperative or Posttraumatic Bile Leakage
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Type
9.7.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
9.7.2. PTC Metal Pancreatic & Biliary Stenting Procedures
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Percutaneous Transhepatic Cholangiography Demand Share Forecast, 2019-2026
10. Latin America Percutaneous Transhepatic Cholangiography Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
10.4.1. Jaundice
10.4.2. Stone Removal
10.4.3. Postoperative or Posttraumatic Bile Leakage
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Type
10.7.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
10.7.2. PTC Metal Pancreatic & Biliary Stenting Procedures
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Percutaneous Transhepatic Cholangiography Demand Share Forecast, 2019-2026
11. Europe Percutaneous Transhepatic Cholangiography Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
11.4.1. Jaundice
11.4.2. Stone Removal
11.4.3. Postoperative or Posttraumatic Bile Leakage
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Percutaneous Transheatic Cholangiography Market Size and Volume Forecast by Type
11.7.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
11.7.2. PTC Metal Pancreatic & Biliary Stenting Procedures
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Percutaneous Transhepatic Cholangiography Demand Share, 2019-2026
12. Asia Pacific Percutaneous Transhepatic Cholangiography Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
12.4.1. Jaundice
12.4.2. Stone Removal
12.4.3. Postoperative or Posttraumatic Bile Leakage
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Type
12.7.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
12.7.2. PTC Metal Pancreatic & Biliary Stenting Procedures
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Percutaneous Transhepatic Cholangiography Demand Share, 2019-2026
13. Middle East & Africa Percutaneous Transhepatic Cholangiography Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Application
13.4.1. Jaundice
13.4.2. Stone Removal
13.4.3. Postoperative or Posttraumatic Bile Leakage
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Percutaneous Transhepatic Cholangiography Market Size and Volume Forecast by Type
13.7.1. PTC Plastic Pancreatic & Biliary Stenting Procedures
13.7.2. PTC Metal Pancreatic & Biliary Stenting Procedures
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Percutaneous Transhepatic Cholangiography Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Percutaneous Transhepatic Cholangiography Market: Market Share Analysis
14.2. Percutaneous Transhepatic Cholangiography Distributors and Customers
14.3. Percutaneous Transhepatic Cholangiography Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. B. Braun Melsungen AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. KARL STORZ
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cardinal Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
